Remarkably, a large number of U2AF1 mutational landscapes in various hematologic tumors have been reported, including MDS, MDS/MPN, MPN, AML, and chronic myeloid leukemia (CML). The gene discussed is U2AF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.